PMDA drug package insert
ケイラーゼSA配合顆粒
PMDA Prescription drug · 株式会社三恵薬品 · package insert Jun 21, 2023
Key facts
| Brand names | ケイラーゼSA配合顆粒 |
|---|---|
| Nonproprietary names | ビオヂアスターゼ２０００配合剤 |
| Companies | 製造販売元／株式会社三恵薬品 |
| Product type | Prescription drug |
| Therapeutic category | 総合消化酵素製剤 |
| Therapeutic category codes | 872339 |
| YJ codes | 2339226D1034 |
| Approval numbers | 23100AMX00045000 |
| Package insert edition | 第2版 |
| Package insert date | Jun 21, 2023 |
| PMDA document key | 300185_2339226D1034_1 |
| PMDA company code | 300185 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: